608
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal

ORCID Icon, , ORCID Icon, ORCID Icon, &
Pages 725-732 | Published online: 03 Mar 2020

References

  • Young LS, Sabel AL, Price CS. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2007;28(11):1247–1254. doi:10.1086/52166017926275
  • Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–1263. doi:10.1086/52919818444865
  • Van Looveren M, Goossens H, Baquero F, et al. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect. 2004;10(8):684–704. doi:10.1111/j.1469-0691.2004.00942.x15301671
  • Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73(4):355–363. doi:10.1016/j.jhin.2009.03.03219700220
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582. doi:10.1128/CMR.00058-0718625687
  • Sunenshine RH, Wright MO, Maragakis LL, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007;13(1):97–103. doi:10.3201/eid1301.06071617370521
  • Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis. 2010;23(4):332–339. doi:10.1097/QCO.0b013e32833ae38b20581674
  • Tripathi P, Gajbhiye S. Prevalence of multidrug resistance, ESBL and MBL production in Acinetobacter spp. Int J Recent Trends Sci Technol. 2013;6(3):139–143.
  • Noyal MJC, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian J Med Res. 2009;129(6):707–712.19692754
  • Isenberg H. Clinical Microbiology Procedure Handbook. 2nd ed. Washington, DC: American Society for Microbiology (ASM); 2007.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing, Supplement M100S. 26th ed. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2016.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Singhal S, Mathur T, Khan S, et al. Evaluation of methods for AmpC β- Lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol. 2005;23(2):120–124. doi:10.4103/0255-0857.1605315928443
  • Tsakris A, Poulou A, Pournaras S, et al. A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother. 2010;65(8):1664–1671. doi:10.1093/jac/dkq21020542902
  • Shrestha S, Tada T, Shrestha B, et al. Phenotypic characterization of multidrug-resistant Acinetobacter baumannii with special reference to metallo-β-lactamase production from the hospitalized patients in a tertiary care hospital in Nepal. JIOM. 2015;37(3):3–10.
  • Saad M, Samawi A, Khan FY, et al. Acinetobacter infections among adult patients in qatar: a 2-year hospital-based study. Canadian J Infect Dis Med Microbiol. 2016. doi:10.1155/2016/6873689
  • Shrestha RK, Dahal RK, Mishra SK, et al. Ventilator-associated pneumonia in tertiary care. JIOM. 2013;35(3):21–28.
  • Mishra SK, Rijal BP, Pokhrel BM. Emerging threat of multidrug resistant bugs – acinetobacter calcoaceticus baumannii complex and Methicillin-resistant Staphylococcus aureus. BMC Res Notes. 2013;6(1):1. doi:10.1186/1756-0500-6-9823281703
  • Xie D, Xiong W, Lai R, et al. Ventilator-associated pneumonia in intensive care units in Hubei Province, China: a multicentre prospective cohort survey. J Hosp Infect. 2011;78(4):284–288. doi:10.1016/j.jhin.2011.03.00921511367
  • Villegas MV, Kattan JN, Quinteros MG, Casellas JM. Prevalence of extended-spectrum beta-lactamases in South America. Clin Microbiol Infect. 2008;14 Suppl 1:154–158. doi:10.1111/j.1469-0691.2007.01869.x18154539
  • Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, −24/40 and −58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY surveillance program. J Antimicrob Chemother. 2009;63(1):55–59. doi:10.1093/jac/dkn43418957398
  • Joseph NM, Sistla S, Dutta TK, Badhe AS, Rasitha D, Parija SC. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multidrug resistant pathogens. J Infect Dev Ctries. 2010;4(4):218–225. doi:10.3855/jidc.63420440059
  • Al-Sweih NA, Al-Hubail MA, Rotimi VO. Emergence of tigecycline and colistin resistance in Acinetobacter species isolated from patients in Kuwait hospitals. J Chemother. 2011;23(1):13–16. doi:10.1179/joc.2011.23.1.1321482488
  • Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokhrel BM. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6(1):67. doi:10.1186/s13756-017-0222-z28638594
  • Safari M, Sasan A, Nejad M, Bahador A. Prevalence of ESBL and MBL encoding genes in Acinetobacter baumannii strains isolated from patients of intensive care units (ICU). Saudi J Biol Sci. 2015;22(4):424–429. doi:10.1016/j.sjbs.2015.01.00426150748
  • Hans R, Bisht D, Agarwal R, Medical S. Phenotypic detection of MBL, AmpC beta-lactamase and carbapenemases in multi drug resistant isolates of Acinetobacter baumannii. Int J Med Res Heal Sci. 2014;4(2):311–316. doi:10.5958/2319-5886.2015.00058.2
  • Tacconelli E, Magrini N, Kahlmeter G, Singh N. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Heal Organ. 2017;27:1–7.
  • Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355–362. doi:10.1016/S1473-3099(11)70059-721478057
  • Shrestha S, Chaudhari R, Karmacharya S, et al. Prevalence of nosocomial lower respiratory tract infections caused by Multidrug resistance pathogens. JIOM. 2011;33(2).
  • Dey A, Bairy I. Incidence of multidrug-resistant organisms causing ventilator-associated pneumonia in a tertiary care hospital: a nine months’ prospective study. Ann Thorac Med. 2007;2(2):52–57. doi:10.4103/1817-1737.3223019727346
  • Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi:10.1016/S1473-3099(13)70190-723969216
  • Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007;51(4):1553–1555. doi:10.1128/AAC.01405-0617261621
  • Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003;41(8):3542–3547. doi:10.1128/JCM.41.8.3542-3547.200312904353